Anita Chakraverty, Author at Labiotech.eu

News and Trends 17 May 2022

US Giant Apollo Bags Billion-Euro Partnership with Sofinnova

As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a €1B collaboration deal with the US investment heavyweight Apollo to nurture life sciences companies. Cementing…

May 17, 2022 - 3 minutesmins - By Anita Chakraverty

News and Trends 6 May 2022

Melt&Marble Gains €5M to Brew Fat Alternatives Using Engineered Yeast

Tapping into the increasingly sophisticated market for meat alternatives, the Swedish synthetic biology startup Melt&Marble has raised €5M in seed financing to fund the development of a fermented fat ingredient…

May 6, 2022 - 4 minutesmins - By Anita Chakraverty

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19…

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 31 Mar 2022

Precision Medicine Startups Increase Focus on Data Access and Privacy

Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and ownership remains a key issue for many individuals. Sano Genetics is one of many firms…

March 31, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 22 Mar 2022

Biotechs Carve out Niches in Cystic Fibrosis Treatment Space

Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus that affects the lungs and other organs. Emerging biotechs such as Kither Biotech as well…

March 22, 2022 - 5 minutesmins - By Anita Chakraverty

argenx efgartigimod treatment autoimmune disease myasthenia gravis

News and Trends 21 Dec 2021

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle disease generalized myasthenia gravis, opening up its developer argenx to billion-dollar revenues. Efgartigimod, to be…

December 21, 2021 - 4 minutesmins - By Anita Chakraverty

London UK venture capital adendra therapeutics apple tree partners

News and Trends 14 Dec 2021

ATP Blazes US Venture Capital Trail into European Biotech Startups

The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray by launching the UK immuno-oncology company Adrendra Therapeutics. This happens as US investors increasingly search…

December 14, 2021 - 4 minutesmins - By Anita Chakraverty

Medical anca associated vasculitis avacopan

News and Trends 1 Dec 2021

Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones

New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis, with a nod towards European approval for a first-in-class drug and positive phase II results…

December 1, 2021 - 4 minutesmins - By Anita Chakraverty

Industrial biotech sustainability environment

News and Trends 18 Nov 2021

Sustainability in Focus as Two VCs Build Industrial Biotech Funds

As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital fundraises from Sofinnova and the European Circular Bioeconomy Fund have led the push for industrial…

November 18, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 12 Nov 2021

Big Pharma Strikes Megadeals In Targeted Protein Degradation

With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed between biotech startups and big pharma in this upcoming area. Novartis, Pfizer, and Bayer have…

November 12, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 4 Nov 2021

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of these therapies is held back by skill shortages. Increasing training programs and automation could form…

November 4, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 22 Oct 2021

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the detection of an unexpected genetic change in a clinical trial.…

October 22, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 1 Oct 2021

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M to the world's first research institution dedicated to capturing carbon dioxide from the air and…

October 1, 2021 - 6 minutesmins - By Anita Chakraverty

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut health. Last…

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 12 Aug 2021

European Biotechs Fire up Deals to Develop Parkinson’s Treatments

Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or license treatments for Parkinson's disease. For some experts, this increasing interest in the brain disease…

August 12, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 6 Aug 2021

Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer

The UK firm Artios Pharma raised a huge Series C round last week in one of many efforts to develop cancer drugs that target the DNA repair systems of our…

August 6, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 30 Jul 2021

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly…

July 30, 2021 - 4 minutesmins - By Anita Chakraverty

uk vc firm investment biotech life sciences

News and Trends 16 Jul 2021

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M) UK government initiative to support the growth of promising late-stage life sciences companies. The UK’s…

July 16, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 12 Jul 2021

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

The French investor Sofinnova Partners has injected a total of €6M into three Italian gene therapy companies, cementing Italy’s reputation as a European center for cell and gene therapies. Last…

July 12, 2021 - 5 minutesmins - By Anita Chakraverty

poxel diabetes Sumitomo Dainippon Pharma

News and Trends 2 Jul 2021

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

As French biotech Poxel marks the first market approval of its oral type 2 diabetes medication in Japan, eyes turn to the future of this drug and its rivals in…

July 2, 2021 - 5 minutesmins - By Anita Chakraverty

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

About

Articles by Anita Chakraverty

Outsourcing in life science R&D today

Are you out-licensing?

Subscribe to our newsletter to get the latest biotech news!